Back
Open Access

End-of-cancer therapy cardiovascular risk assessment and long-term follow-up.

Session: 2022 ESC Guidelines on cardio-oncology
Topic: Cardio-Oncology
Speaker: Professor T. Suter (Bern, CH)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Professor Thomas Suter

Bern University Hospital, Inselspital, Bern (Switzerland)
19 presentations
5 followers

3 more presentations in this session

Cardiovascular toxicity risk stratification before anticancer therapy.

Speaker: Doctor E. de Azambuja (Brussels, BE)

Access
Slides
Video
Like
Thumbnail

Prevention and monitoring of cardiovascular complications during cancer therapy.

Speaker: Professor J. Bergler-Klein (Vienna, AT)

Access
Slides
Video
Like
Thumbnail

Diagnosis and management of acute and subacute CVDs in patients with active cancer.

Speaker: Associate Professor D. Farmakis (Athens, GR)

Access
Slides
Video
Like
Thumbnail

Access the full session

2022 ESC Guidelines on cardio-oncology

Speakers: Professor T. Suter, Doctor E. de Azambuja, Professor J. Bergler-Klein, Associate Professor D. Farmakis
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

Related content

Open Access

Cardiovascular toxicity risk stratification before anticancer therapy.

27 August 2022

Open Access

Prevention and monitoring of cardiovascular complications during cancer therapy.

27 August 2022

Open Access

Diagnosis and management of acute and subacute CVDs in patients with active cancer.

27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources